UNSPSC 85703575: Supplement left upper femur with nonautologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left upper femur with nonautologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0QU73KZ

UNSPSC 85703575 Supplement left upper femur with nonautologous tissue substitute, percutaneous approach is a Commodity code that does not align with recent state and local procurement activity. The code nominally describes an orthopedic surgical procedure involving placement of a tissue substitute in the upper femur via percutaneous approach—a specific medical device or procedural service typically purchased by hospitals, surgical centers, or health systems as part of clinical care operations. However, the six recent state and local opportunities tagged to this code involve independent medical evaluation services, pharmacy benefit management, occupational medical surveillance, specialty surgical benefits programs through Centers of Excellence networks, and temporary health professional staffing—none of which involve orthopedic implant procurement or femoral reconstruction procedures. The mismatch suggests either a coding error in the opportunities block or a fundamental misclassification at the source level.

The recent opportunities do span multiple issuing bodies—the City of Phoenix Retirement Office (disability medical evaluations), City of Long Beach (surgical benefits carve-out), Washington State Department of Transportation (occupational medical surveillance), Harris County Juvenile Probation Department (emergency and specialty medical services for detained youth), Collier County Board of County Commissioners (pharmacy benefit management), and County of Santa Clara Health System (temporary health professional staffing)—and cover Arizona, California, Washington, Florida, and Texas. Without recent opportunities that actually involve orthopedic implants, femoral reconstruction, or percutaneous tissue substitutes, the code shows little actionable procurement signal for vendors in the implant, device, or surgical-procedure-supply space.